346264 <common-name>N-(5-bromo-1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide</common-name> <description>N-(5-bromo-1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide is a chemical compound with the formula C27H26BrN3O3S. With an average molecular weight of 552.50 g/mol, N-(5-bromo-1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide is a heavy molecule.</description> <cas>476483-19-9</cas> <pubchem-id>4167332</pubchem-id> <chemical-formula>C27H26BrN3O3S</chemical-formula> <weight>552.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T09:39:40Z</created-at> <updated-at type="dateTime">2026-08-31T09:39:40Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C(C2=C(N1)CC(CC2=O)(C)C)C3=CC=C(C=C3)OC)C(=O)NC4=NC5=C(S4)C=CC(=C5)Br</moldb-smiles> <moldb-formula>C27H26BrN3O3S</moldb-formula> <moldb-inchi>InChI=1S/C27H26BrN3O3S/c1-14-22(25(33)31-26-30-18-11-16(28)7-10-21(18)35-26)23(15-5-8-17(34-4)9-6-15)24-19(29-14)12-27(2,3)13-20(24)32/h5-11,23,29H,12-13H2,1-4H3,(H,30,31,33)</moldb-inchi> <moldb-inchikey>UQPUUONRDXLXHV-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">551.08783</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM342157</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-(5-bromo-1,3-benzothiazol-2-yl)-4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Quinolines and derivatives</klass> <subklass>Phenylquinolines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0296617</sync-id> <structure-inchikey>UQPUUONRDXLXHV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400200000000000000000000000c040000000000024200000000000002041000000000000000000000002000040000000000000002000000000000080000020000030000100000a0080000100020004000001000001004000000010040000040002000800004200080000000010000000004800010000400020000000008400100c000000000000000000000021000004000000000000000000080200000000000000000080000100000000000080000000000200000000000100001000000000000000002000000200000000000010008000000001000040000000000400000000000000000000000000002000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAQMGACgAAAAD BAYAKAAAAAMEBgBgAAAAAwEGACgAAAADBAYAKAAAAAMEBwBoAAAAAwIBBgBg AAAAAgIGACAAAAAEBgBgAAAAAgIGACgAAAADBAgAKAAAAAMCBgBgAAAAAQMG AGAAAAABAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEIACgAAAADAgYAYAAAAAEDBgAoAAAAAwQIACgAAAAD AgcAaAAAAAMCAQZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAZAKAAAAAMEEEAo AAAAAwIGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDASMAIAAA AAELAAEAAQIoAgIDAAMEAAQFKAIFBiAFBwAHCAAICQAJCgAKCygCCAwACA0A Aw4ADg9oDA8QaAwQEWgMERJoDBITaAwRFCAUFQACFiAWFygCFhggGBkgGRpo DBobaAwbHGgMHB1oDBweaAweH2gMHyBoDCAhaAwgIgAGASAKBCATDmgMHRlo DCEbaAxCBQAAAAYBBgUEAwIGBwgJCgQFBg8QERITDgUaGR0cGwYeHyAhGxwX BAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:45:02Z</structure-indexed-at> </compound>